MYIA
ARRY

Mount Yale Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Mount Yale Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,739
Closed -$30K – 922
2018
Q3 		$30K Sell
1,739
-100
-5% -$1.53K 0.01% 706
2018
Q2 		$31K Buy
1,839
+841
+84% +$13.4K 0.01% 719
2018
Q1 		$16K Buy
+998
New +$16K ﹤0.01% 807

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Mount Yale Investment Advisors's ARRY Position: Q4 2018 in Review

Mount Yale Investment Advisors sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 1,739 shares — an estimated $30K sold.

Mount Yale Investment Advisors first reported a position in ARRY in Q1 2018 and held it in 3 quarters. The position peaked at $31K in Q2 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Mount Yale Investment Advisors reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 1,739 Array Biopharma Inc shares in Q4 2018, an estimated $30K.
  • Mount Yale Investment Advisors first reported a position in Array Biopharma Inc in Q1 2018 and held it in 3 quarters.
  • Mount Yale Investment Advisors's Array Biopharma Inc position peaked at $31K in Q2 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.